TRDA
Entrada Therapeutics, Inc. · Healthcare
CEO Dipal Doshi sold $34K of Entrada Therapeutics, Inc.
Sold$33,897
$17.84Price
1,900Shares
−1%Stake
What TRDA did after the filing
- The stock from Tue, Jul 16 close, $17.76
- −6.0%
- S&P 500, same days
- −0.6%
Measured over 30 trading days, to the Aug 27 close.
Traded Fri, Jul 12. Filed Tue, Jul 16, 12:42 PM ET, during the session. Returns use the Jul 16 close and the Aug 27 close. Not investment advice.